A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
Clinical trial NCT05898620 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05898620
- Sponsor
- Neurogene Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2029-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.